State of Wisconsin Investment Board
SNDX icon

State of Wisconsin Investment Board’s Syndax Pharmaceuticals SNDX Stock Holding History

State of Wisconsin Investment Board’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$988K Sell
45,209
-637
-1% -$13.2K ﹤0.01% 1785
2026
Q1 		$1.07M Buy
45,846
+5,085
+12% +$110K ﹤0.01% 1659
2025
Q4 		$856K Sell
40,761
-9,569
-19% -$167K ﹤0.01% 1733
2025
Q3 		$774K Sell
50,330
-90,783
-64% -$1.19M ﹤0.01% 1711
2025
Q2 		$1.32M Buy
141,113
+77,006
+120% +$848K ﹤0.01% 1473
2025
Q1 		$788K Buy
64,107
+10,978
+21% +$155K ﹤0.01% 1578
2024
Q4 		$702K Buy
53,129
+12,944
+32% +$222K ﹤0.01% 1658
2024
Q3 		$774K Sell
40,185
-12,102
-23% -$250K ﹤0.01% 1670
2024
Q2 		$1.07M Buy
52,287
+11,086
+27% +$232K ﹤0.01% 1538
2024
Q1 		$981K Sell
41,201
-37,557
-48% -$838K ﹤0.01% 1436
2023
Q4 		$1.7M Buy
78,758
+24,302
+45% +$374K ﹤0.01% 1267
2023
Q3 		$791K Buy
54,456
+7,400
+16% +$140K ﹤0.01% 1485
2023
Q2 		$985K Sell
47,056
-5,333
-10% -$111K ﹤0.01% 1464
2023
Q1 		$1.11M Sell
52,389
-1,058
-2% -$26.3K ﹤0.01% 1447
2022
Q4 		$1.36M Buy
53,447
+7,234
+16% +$169K ﹤0.01% 1412
2022
Q3 		$1.11M Buy
46,213
+2,639
+6% +$59.2K ﹤0.01% 1500
2022
Q2 		$838K Sell
43,574
-14,626
-25% -$244K ﹤0.01% 1756
2022
Q1 		$1.01M Hold
58,200
– – ﹤0.01% 1642
2021
Q4 		$1.27M Sell
58,200
-16,400
-22% -$303K ﹤0.01% 1374
2021
Q3 		$1.43M Sell
74,600
-1,400
-2% -$23.3K ﹤0.01% 1356
2021
Q2 		$1.3M Buy
76,000
+22,500
+42% +$412K ﹤0.01% 1376
2021
Q1 		$1.2M Buy
53,500
+2,700
+5% +$61K ﹤0.01% 1323
2020
Q4 		$1.13M Sell
50,800
-7,000
-12% -$145K ﹤0.01% 1297
2020
Q3 		$853K Buy
57,800
+17,600
+44% +$268K ﹤0.01% 1328
2020
Q2 		$596K Buy
40,200
+3,500
+10% +$53.3K ﹤0.01% 1373
2020
Q1 		$403K Buy
36,700
+6,600
+22% +$61.9K ﹤0.01% 1406
2019
Q4 		$264K Hold
30,100
– – ﹤0.01% 1558
2019
Q3 		$225K Buy
30,100
+10,900
+57% +$99.3K ﹤0.01% 1494
2019
Q2 		$179K Buy
19,200
+400
+2% +$2.92K ﹤0.01% 1494
2019
Q1 		$99K Buy
18,800
+4,400
+31% +$25.1K ﹤0.01% 1506
2018
Q4 		$64K Buy
+14,400
New +$78.9K ﹤0.01% 1513

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

State of Wisconsin Investment Board's SNDX Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its Syndax Pharmaceuticals (SNDX) stake by 1.4% in Q2 2026, selling an estimated $13.2K and leaving 45,209 shares worth $988K. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

State of Wisconsin Investment Board first reported a position in SNDX in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.7M in Q4 2023. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • State of Wisconsin Investment Board held 45,209 shares of Syndax Pharmaceuticals worth $988K as of Q2 2026.
  • State of Wisconsin Investment Board sold 637 Syndax Pharmaceuticals shares in Q2 2026, an estimated $13.2K.
  • Syndax Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1785 holding.
  • State of Wisconsin Investment Board first reported a position in Syndax Pharmaceuticals in Q4 2018 and has held it in 31 quarters since.
  • State of Wisconsin Investment Board's Syndax Pharmaceuticals position peaked at $1.7M in Q4 2023.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.